Jushi Holdings (JUSHF) Total Current Liabilities (2021 - 2026)
Jushi Holdings (JUSHF) posted quarterly Total Current Liabilities of $93.2 million for Q2 2026, up 47.61% year-over-year from $63.1 million in Q2 2025, and up 24.09% quarter-over-quarter from $75.1 million in Q1 2026.
Jushi Holdings (JUSHF) Total Current Liabilities (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has reported Total Current Liabilities for 6 consecutive years, with $93.2 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Total Current Liabilities rose 47.61% year-over-year to $93.2 million; the TTM figure through Jun 2026 stood at $93.2 million (up 47.61% YoY), while the FY2025 annual figure was $66.2 million, down 3.93% from the prior year.
- Total Current Liabilities grew to $93.2 million in Q2 2026 per JUSHF's latest filing, from $75.1 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $228.7 million in Q3 2022 and bottomed at $60.6 million in Q1 2025.
- Historically, Total Current Liabilities has averaged $109.3 million across 5 years, with a median of $107.6 million in 2022.
- On a YoY basis, Total Current Liabilities climbed as much as 56.47% in 2025 and fell as far as 63.13% in 2025.
- Jushi Holdings' Total Current Liabilities stood at $107.6 million in 2022, then surged by 50.95% to $162.5 million in 2023, then sank by 57.59% to $68.9 million in 2024, then declined by 3.93% to $66.2 million in 2025, then jumped by 40.78% to $93.2 million in 2026.
- Business Quant data shows JUSHF's Total Current Liabilities at $93.2 million in Q2 2026, $75.1 million in Q1 2026, and $66.2 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | -8.38 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 15.65 Bn |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | 2.06 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 17.34 Bn |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | 607.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 6.35 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 874.50 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 1.85 Bn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | 1.79 Bn |
| 10 | Jushi Holdings | 83.87 Mn | 50.54 Mn | 31.53 Mn | 93.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 93.17 Mn |
| Mar 31, 2026 | 75.09 Mn |
| Dec 31, 2025 | 66.19 Mn |
| Sep 30, 2025 | 109.19 Mn |
| Jun 30, 2025 | 63.12 Mn |
| Mar 31, 2025 | 60.58 Mn |
| Dec 31, 2024 | 68.90 Mn |
| Sep 30, 2024 | 69.78 Mn |
| Jun 30, 2024 | 73.73 Mn |
| Mar 31, 2024 | 164.30 Mn |
| Dec 31, 2023 | 162.46 Mn |
| Sep 30, 2023 | 116.26 Mn |
| Jun 30, 2023 | 127.62 Mn |
| Mar 31, 2023 | 115.29 Mn |
| Dec 31, 2022 | 107.63 Mn |
| Sep 30, 2022 | 228.67 Mn |
| Jun 30, 2022 | 156.58 Mn |
| Dec 31, 2021 | 83.93 Mn |